Clinical Trials
40 trialsDESTINY-B12
AstraZeneca
LIMITLESS
InSightec
IPAX BrIGHT
Telix Pharmaceuticals (Innovations) Pty Limited
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
NaviFUS Corporation
GDX-44-016
Guerbet
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
NovoCure Ltd.
Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)
GT Medical Technologies, Inc.
Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma
HUYABIO International, LLC.
STAR-3
Kintara Therapeutics, Inc.
REVELATE
Blue Earth Diagnostics
CheckMate548
Bristol-Myers Squibb
CSCRGBM
Cordgenics, LLC
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Sumitomo Pharma America, Inc.
Intellance1
AbbVie
ANGLeD
Angiochem Inc
CheckMate 498
Bristol-Myers Squibb
METRICS
Health Clinics Limited
GBM
Northwest Biotherapeutics
STELLAR
Orbus Therapeutics, Inc.
Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
Spectrum Pharmaceuticals, Inc
SMART
Betta Pharmaceuticals Co., Ltd.
Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer
Novartis
ACT IV
Celldex Therapeutics
SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
Bayer
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
NovoCure Ltd.
Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis
Bayer
SAPPHIRE
Isarna Therapeutics GmbH
XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
Celtic Pharma Development Services
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
Pharmacyclics LLC.
ENRICH
Spectrum Pharmaceuticals, Inc
SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
Pfizer
An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
Celtic Pharma Development Services
Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
NovoCure Ltd.
Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid
medac GmbH
The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
INSYS Therapeutics Inc
Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
Novartis
Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
Xenova Biomedix
XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
Celtic Pharma Development Services
Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)
Pharmacyclics LLC.